249 related articles for article (PubMed ID: 2939871)
1. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
Lehtonen A; Himanen P; Saraste M; Niittymäki K; Marniemi J
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
[TBL] [Abstract][Full Text] [Related]
2. Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
Frick MH; Cox DA; Himanen P; Huttunen M; Pitkäjärvi T; Pörsti P; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
Am J Cardiol; 1987 May; 59(14):61G-67G. PubMed ID: 2884854
[TBL] [Abstract][Full Text] [Related]
3. A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.
Frick MH; Halttunen P; Himanen P; Huttunen M; Pörsti P; Pitkäjärvi T; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):55S-62S. PubMed ID: 2939868
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
Talseth T; Westlie L; Daae L; Vatle S
Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
[TBL] [Abstract][Full Text] [Related]
5. Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study.
Rabkin SW; Huff MW; Newman C; Sim D; Carruthers SG
Hypertension; 1994 Aug; 24(2):241-8. PubMed ID: 8039850
[TBL] [Abstract][Full Text] [Related]
6. Long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Lijnen P; Fagard R; Staessen J; Lissens W; Amery A
J Cardiovasc Pharmacol; 1989 Aug; 14(2):319-25. PubMed ID: 2476608
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
Lijnen P; Fagard R; Staessen J; Amery A
Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197
[TBL] [Abstract][Full Text] [Related]
8. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
Nash DT; Schonfeld G; Reeves RL; Black H; Weidler DJ
Am J Cardiol; 1987 May; 59(14):87G-90G. PubMed ID: 2884859
[TBL] [Abstract][Full Text] [Related]
9. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
Talseth T; Westlie L; Daae L
J Hum Hypertens; 1990 Oct; 4 Suppl 3():39-44. PubMed ID: 2148194
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Ott P; Storm TL; Krusell LR; Jensen H; Badskjaer J; Faergeman O
Am J Cardiol; 1987 May; 59(14):73G-77G. PubMed ID: 2884856
[TBL] [Abstract][Full Text] [Related]
11. The antihypertensive effects of doxazosin: a clinical overview.
Cox DA; Leader JP; Milson JA; Singleton W
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):83S-90S. PubMed ID: 2939872
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
Talseth T; Westlie L; Daae LN
J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive effect of doxazosin in hypertensive patients: comparison with atenolol.
Baez MA; Garg DC; Jallad NS; Weidler DJ
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):63S-67S. PubMed ID: 2939869
[TBL] [Abstract][Full Text] [Related]
14. Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.
Torvik D; Madsbu HP
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):69S-75S. PubMed ID: 2939870
[TBL] [Abstract][Full Text] [Related]
15. Doxazosin versus atenolol: a randomized comparison of calculated coronary heart disease risk reduction.
Mazzola C; Guerrasio E
Am Heart J; 1988 Dec; 116(6 Pt 2):1797-801. PubMed ID: 2904753
[TBL] [Abstract][Full Text] [Related]
16. Short-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Lijnen P; Fagard R; Staessen J; Amery A
J Cardiovasc Pharmacol; 1988 Oct; 12(4):461-6. PubMed ID: 2465447
[TBL] [Abstract][Full Text] [Related]
17. Doxazosin and atenolol as monotherapy in mild and moderate hypertension: a randomized, parallel study with a three-year follow-up.
Talseth T; Westlie L; Daae L
Am Heart J; 1991 Jan; 121(1 Pt 2):280-5. PubMed ID: 1824651
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
Trost BN; Weidmann P; Riesen W; Claessens J; Streulens Y; Nelemans F
Am J Cardiol; 1987 May; 59(14):99G-104G. PubMed ID: 2884861
[TBL] [Abstract][Full Text] [Related]
19. Alpha-1 adrenoceptor blockade with doxazosin in hypertension: effects on blood pressure and lipoproteins.
Ames RP; Kiyasu JY
J Clin Pharmacol; 1989 Feb; 29(2):123-7. PubMed ID: 2565917
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics and pharmacodynamics of doxazosin compared with atenolol during long-term double-blind treatment.
Faulkner JK; Himanen P; Karjalainen U; Saraste M
Eur J Clin Pharmacol; 1987; 31(6):685-93. PubMed ID: 2951261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
